Research articlePublished 2011
Differences in Relative Bioavailability (BA) of Inhalation Insulin Determined using Insulin and Glucose Levels Following Subcutaneous and Inhalation Administration in Humans
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
BA may be determined using both plasma concentrations of a drug (pharmacokinetic parameters) and its pharmacological effects (pharmacodynamic parameters). However, the resulting assessments of BA can be substantially different. In a relative BA study (N=30) 10 IU (0.35 mg) Actrapid ® was administered subcutaneously with comparison to a 6.5 mg dose of recombinant human insulin inhalation powder (RHIIP) administered using the Cyclohaler TM dry powder inhaler under euglycemic glucose clamp conditions. Relative BA following the inhalation administration compared with the subcutaneous dose was 12.0±1.8% and 6.3±0.6% when determined using baseline-adjusted insulin and glucose infusion rate (GIR), respectively. To explain the observed differences in BA, a pharmacokinetic-pharmacodynamic model was developed and BAs were predicted at different doses of inhalation insulin with the fixed 10 IU subcutaneous dose. BA predicted for 3.25 mg inhaled insulin and GIR were 12% and 7.5%, respectively. When the potency of the two insulin formulations was compared, it was shown that Actrapid ® was approximately 1.4 times greater than the RHIIP formulation. Furthermore, when AUC values for GIR were normalized based on potency BA predicted for a 3.25 mg RHIIP dose was approximately 11%. Thus, the difference in BA dependent upon insulin and glucose could be explained by the non-linear pharmacokinetic-pharmacodynamic relationship and potency difference between RHIIP and Actrapid ® .
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Bioequivalence & Bioavailability
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Chyung S. Cook”
- BylineArticles whose byline prints “Paul W. Valaitis”
- BylineArticles whose byline prints “Andrew Brugger”
- BylineArticles whose byline prints “Tim Heise”
- BylineArticles whose byline prints “Jerry Gass”
- BylineArticles whose byline prints “Laura Anderson”
- BylineArticles whose byline prints “Janice Troeger”
- BylineArticles whose byline prints “Steve White”